B Cell News and Research

RSS
Unraveling the mechanisms of B-cell maturation in blood cancer

Unraveling the mechanisms of B-cell maturation in blood cancer

Discovery of antibodies that boost complement activation against K. pneumoniae

Discovery of antibodies that boost complement activation against K. pneumoniae

Researchers identify a protein that recharges T cells for long-lasting cancer remission

Researchers identify a protein that recharges T cells for long-lasting cancer remission

UMC Utrecht study uncovers 29 novel antibodies against Klebsiella pneumoniae

UMC Utrecht study uncovers 29 novel antibodies against Klebsiella pneumoniae

Why children with Down’s syndrome are predisposed to developing leukaemia

Why children with Down’s syndrome are predisposed to developing leukaemia

New two-dose HIV vaccine strategy shows promise for stronger immune response

New two-dose HIV vaccine strategy shows promise for stronger immune response

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

Phase 1 trial shows safety and efficacy of personalized vaccine for lymphoplasmacytic lymphoma

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

Lupus Research Alliance announces 2024 Diversity in Lupus Research Award recipients

B cell abnormalities identified as potential biomarkers for triple negative breast cancer treatment response

B cell abnormalities identified as potential biomarkers for triple negative breast cancer treatment response

Artificial lymphoid organ-chips created to predict vaccine responses in humans

Artificial lymphoid organ-chips created to predict vaccine responses in humans

Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections

Mucosal COVID-19 boosters outperform mRNA shots in preventing upper airway infections

Cross-reactive T cells link SARS-CoV-2 to autoimmune triggers in MIS-C

Cross-reactive T cells link SARS-CoV-2 to autoimmune triggers in MIS-C

USC scientists transform B cells into cancer and HIV destroyers

USC scientists transform B cells into cancer and HIV destroyers

CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma

CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma

Study reveals early immune responses to SARS-CoV-2, offering insights for future COVID-19 treatments

Study reveals early immune responses to SARS-CoV-2, offering insights for future COVID-19 treatments

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

Innovative CAR T cell therapy shows promise for relapsed CIDP patients

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

Non-chemotherapy treatment regimen achieves full remission in aggressive B-cell lymphoma

Unveiling the role of auto-antibodies in COVID-19 severity

Unveiling the role of auto-antibodies in COVID-19 severity

Unlocking the role of B cells in neuromyelitis optica spectrum disorder treatment

Unlocking the role of B cells in neuromyelitis optica spectrum disorder treatment

New strategy targets rare B cells for effective HIV vaccine development

New strategy targets rare B cells for effective HIV vaccine development

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.